Tenet Reports Fourth Quarter and FY 2022 Results; Provides 2023 Financial Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Tenet Healthcare (THC) Tops Q4 EPS by 73c; Guides
February 9, 2023 6:58 AM ESTTenet Healthcare (NYSE: THC) reported Q4 EPS of $1.96, $0.73 better than the analyst estimate of $1.23. Revenue for the quarter came in at $4.99 billion versus the consensus estimate of $4.91 billion.
GUIDANCE:
Tenet Healthcare sees Q1 2023 EPS of $1.00-$1.23. Tenet Healthcare sees Q1... More
